JD Supra

SEC expands confidential review of registration statements

The SEC recently announced new accommodations to expand the types of companies and registration statements eligible for confidential SEC review. In this post, we summarize key takeaways from the ...
JD Supra

SEC Staff Expands Draft Registration Statement Accommodations

On March 3, 2025, the staff of the U.S. Securities and Exchange Commission’s (the “SEC”) Division of Corporation Finance (the “SEC staff”) announced that, effective immediately, it is enhancing the ...
Crowdfund Insider

SEC to No Longer Stay Effectiveness of Registration Statement Once Securities Sold, Impacts Reg A

The Securities and Exchange Commission (SEC) made some rule changes today, and one of them will impact Regulation A (Reg A), a securities exemption utilized for online capital formation. Reg A ...

Vicore Pharma Pursues US Dual Listing, Files Registration Statement with the SEC

Proposed dual listing expected to broaden access to US investors as buloxibutid advances toward its Phase 2b readout in IPF, with no concurrent financing or share offering planned STOCKHOLM, SWEDEN ...
Nasdaq

The Metals Royalty Company Inc. Announces Public Filing of Registration Statement for Proposed Direct Listing of Its Common Shares

LONDON, UK / ACCESS Newswire / March 2, 2026 / The Metals Royalty Company Inc. ("TMCR" or the "Company"), a purpose-built financing platform dedicated to advancing U.S. critical mineral security and ...

JFB and XTEND Announce Filing of Registration Statement on Form S-4 with the SEC in Connection with their Proposed Business Combination

Filing Represents Critical Step in the Business Combination ~~ Combined Company to be Renamed XTEND AI Robotics and Expected ...
Nasdaq

ReserveOne Announces Filing of Registration Statement on Form S-4 with the SEC for Proposed Business Combination with M3-Brigade Acquisition V Corp.

NEW YORK, Dec. 08, 2025 (GLOBE NEWSWIRE) -- ReserveOne, Inc. (“ReserveOne”) and ReserveOne Holdings, Inc. (“Pubco”) today announced that, in connection with the previously disclosed proposed business ...

Vicore Pharma Holding: Vicore Pharma Pursues US Dual Listing, Files Registration Statement with the SEC

Proposed dual listing expected to broaden access to US investors as buloxibutid advances toward its Phase 2b readout in IPF, with no concurrent financing or share offering planned STOCKHOLM, SWEDEN AN ...